Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
13.09
-1.36 (-9.41%)
At close: Dec 18, 2024, 4:00 PM
13.00
-0.09 (-0.69%)
Pre-market: Dec 19, 2024, 4:36 AM EST
Wave Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 53.61 | 113.31 | 3.65 | 40.96 | 20.08 | 15.98 | |
| Revenue Growth (YoY) | -37.29% | 3005.10% | -91.09% | 104.03% | 25.61% | 10.89% | |
| Cost of Revenue | 149.11 | 130.01 | 115.86 | 121.88 | 130.94 | 175.43 | |
| Gross Profit | -95.5 | -16.7 | -112.21 | -80.91 | -110.87 | -159.45 | |
| Selling, General & Admin | 56.55 | 51.29 | 50.51 | 46.11 | 42.51 | 48.87 | |
| Operating Expenses | 56.55 | 51.29 | 50.51 | 46.11 | 42.51 | 48.87 | |
| Operating Income | -152.05 | -68 | -162.72 | -127.02 | -153.38 | -208.32 | |
| Interest & Investment Income | 8.27 | 7.93 | 1.57 | 0.03 | 0.57 | 4.94 | |
| Other Non Operating Income (Expenses) | 1.27 | 1.88 | 0.01 | 4.54 | 2.06 | 9.74 | |
| Pretax Income | -142.52 | -58.19 | -161.14 | -122.45 | -150.75 | -193.64 | |
| Income Tax Expense | - | -0.68 | 0.68 | -0.2 | -0.84 | - | |
| Net Income | -142.52 | -57.51 | -161.82 | -122.25 | -149.91 | -193.64 | |
| Net Income to Common | -142.52 | -57.51 | -161.82 | -122.25 | -149.91 | -193.64 | |
| Shares Outstanding (Basic) | 126 | 106 | 79 | 52 | 39 | 34 | |
| Shares Outstanding (Diluted) | 126 | 106 | 79 | 52 | 39 | 34 | |
| Shares Change (YoY) | 23.17% | 34.55% | 52.16% | 32.11% | 15.83% | 16.90% | |
| EPS (Basic) | -1.14 | -0.54 | -2.05 | -2.36 | -3.82 | -5.72 | |
| EPS (Diluted) | -1.14 | -0.54 | -2.05 | -2.36 | -3.82 | -5.72 | |
| Free Cash Flow | -141.83 | -20.55 | -129.14 | -89.55 | -117.32 | -192.15 | |
| Free Cash Flow Per Share | -1.13 | -0.19 | -1.64 | -1.73 | -2.99 | -5.67 | |
| Gross Margin | -178.14% | -14.74% | - | -197.52% | - | - | |
| Operating Margin | -283.63% | -60.01% | -4459.30% | -310.07% | -763.94% | -1303.37% | |
| Profit Margin | -265.84% | -50.76% | -4434.72% | -298.42% | -746.68% | -1211.52% | |
| Free Cash Flow Margin | -264.55% | -18.13% | -3539.11% | -218.61% | -584.35% | -1202.21% | |
| EBITDA | -147.98 | -63 | -156.15 | -119.53 | -145.26 | -200.73 | |
| EBITDA Margin | -276.03% | -55.60% | - | -291.80% | - | - | |
| D&A For EBITDA | 4.07 | 5 | 6.57 | 7.48 | 8.11 | 7.59 | |
| EBIT | -152.05 | -68 | -162.72 | -127.02 | -153.38 | -208.32 | |
| EBIT Margin | -283.63% | -60.01% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.